Despite Higher Body Fat Content, Ecuadorian Subjects with Laron Syndrome Have Less Insulin Resistance and Lower Incidence of Diabetes Than Their Relatives
Overview
Authors
Affiliations
In the present pandemics of obesity and insulin resistant diabetes mellitus (DM), the specific contribution of etiological factors such as shifts in nutritional and exercise patterns, genetic and hormonal, is subject of ongoing research. Among the hormonal factors implicated, we selected obesity-driven insulin resistance for further evaluation. It is known that growth hormone (GH) has profound effects on carbohydrate metabolism. In consequence, we compared the effects of the lack of the counter-regulatory effects of GH, in a group of subjects with GH receptor deficiency (GHRD) due to a mutated GH receptor vs. that of their normal relatives. It was found that, despite their obesity, subjects with GHRD, have diminished incidence of diabetes, lower glucose and insulin concentrations, and lower values of indexes indicative of insulin resistance such as HOMA-IR. The GHRD subjects were also capable of appropriately handling glucose or mixed meal loads despite diminished insulin secretion. These observations allow us to suggest that the association of obesity with increased risk for diabetes appears to be dependent on intact growth hormone signaling.
Yuen K, Hjortebjerg R, Ganeshalingam A, Clemmons D, Frystyk J Front Endocrinol (Lausanne). 2024; 15():1456195.
PMID: 39665021 PMC: 11632222. DOI: 10.3389/fendo.2024.1456195.
High growth hormone serum partially protects mice against Trypanosoma cruzi infection.
Mora-Criollo P, Basu R, Qian Y, Funk K, Bell S, Young J FEBS Open Bio. 2023; 13(7):1346-1356.
PMID: 37163287 PMC: 10315831. DOI: 10.1002/2211-5463.13627.
Secondary diabetes mellitus in acromegaly.
Moustaki M, Paschou S, Xekouki P, Kotsa K, Peppa M, Psaltopoulou T Endocrine. 2023; 81(1):1-15.
PMID: 36882643 PMC: 10239382. DOI: 10.1007/s12020-023-03339-1.
Garmes H, Castillo A, Monte Alegre S, de Souza A, Atala Y, Zantut-Wittmann D Metabolites. 2022; 12(12).
PMID: 36557289 PMC: 9782045. DOI: 10.3390/metabo12121251.
The effects of growth hormone on therapy resistance in cancer.
Basu R, Kopchick J Cancer Drug Resist. 2020; 2:827-846.
PMID: 32382711 PMC: 7204541. DOI: 10.20517/cdr.2019.27.